brand logo

Am Fam Physician. 2003;67(8):1782

Clinical Question: Can probiotics decrease the likelihood of antibiotic-associated diarrhea?

Setting: Outpatient (any)

Study Design: Meta-analysis (randomized controlled trials)

Synopsis: Probiotics are living microorganisms used to colonize the intestine to prevent or alleviate disease. The most common probiotics are Lactobacillus spp. and Saccharomyces spp. The researchers who conducted this meta-analysis did a comprehensive search of the published and unpublished literature on probiotics.

Out of 41 studies, only seven were randomized, placebo-controlled, and provided at least two weeks of data (n = 881). The researchers assessed the quality of the studies but did not provide information about blinding, concealed allocation, or method of analysis. Two of the studies involved infants and children. Four studies evaluated Lactobacillus spp., and three studies evaluated Saccharomyces boulardi. A variety of antibiotics was used in the studies, and primary outcome was the occurrence of diarrhea during the course of treatment. Two additional studies have been published since the completion of this meta-analysis, and an extended meta-analysis with more useful data is available online atwww.jr2.ox.ac.uk/bandolier/band104/b104-2.html.

The relative risk of diarrhea during antibiotic therapy was decreased by 40 percent with the use of probiotics (relative risk: 0.6; 95 percent confidence interval [CI]: 0.4 to 0.7). In other words, for every 10 patients given a pro-biotic/antibiotic combination (which sounds counterintuitive), one patient will be prevented from experiencing diarrhea (number needed to treat [NNT]: 10; 95 percent CI: 7.1 to 17). In the United States, where these products are not regulated, the usual caveats apply—we cannot be sure that products actually contain these ingredients or in what quantities.

Bottom Line: Probiotics that contain species of Lactobacillus or Saccharomyces decrease the likelihood of diarrhea from antibiotics in children or adults (absolute risk reduction: 13 to 23 percent; NNT: 10). Tell patients to look for these products in the “diarrhea section” of the pharmacy. A typical dosage is 5 to 10 billion viable organisms administered three to four times a day. The probiotics should be separated from the antibiotics by a couple of hours. (Level of Evidence: 1a)

Continue Reading


More in AFP

Copyright © 2003 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See https://www.aafp.org/about/this-site/permissions.html for copyright questions and/or permission requests.